shutterstock_105336671.Derek Jeter

NEA pitches in for Derek Jeter’s company The Players’ Tribune

New Enterprise Associates has led a $9.5 million Series B funding round for The Players’ Tribune, a New York-based media company founded by Derek Jeter and which posts content from athletes. Jeter launched the site last October. Joining NEA in the Series B round are existing investors, including Thomas Tull of Legendary Entertainment. As part of the funding, Jon Sakoda, general partner of NEA, has joined the board.

XTuit racks up $22 mln in NEA-led round

Cambridge, Massachusetts-based biopharmaceutical company XTuit Pharmaceuticals Inc has secured $22 million in Series A funding. New Enterprise Associates led the round with participation from Polaris Partners, CTI Life Sciences, Arcus Ventures and Omega Funds. In addition to the funding, David Mott, a general partner at New Enterprise Associates, has been appointed to XTuit’s board.


Shipping app Fetchr grabs $11 mln

Shipping app Fetchr has secured $11 million in Series A funding. New Enterprise Associates led the round. Fetchr’s other backers include Triple Point Capital, Endeavor Catalyst, Winklevoss Capital and Delta Partners.


TabbedOut snaps up $21.5 mln Series C

TabbedOut, a mobile payment app for bars and restaurants, has raised $21.5 million in Series C funding. Wellington Management Company led the round with participation from return backers New Enterprise Associates and Morgan Creek Capital Management.


Nomination app Blend raises Series A round led by NEA

San Francisco-based Blend announced it has raised $6.3 Million in a Series A round led by New Enterprise Associates. Metamorphic Ventures, Red Sea Ventures, Great Oaks Capital, the Al Nowais family from Dubai’s Waha Capital and previous investors CAA Ventures, Foundation Capital, Galvanize Ventures, BaseVC, among others, also participated in the round. As part of the funding, Sheel Tyle, a principal with NEA, has joined the board. Blend previously raised $2.7 million in seed funding.


GumGum rakes in $26 mln Series C

Advertising platform GumGum has raised $26 million in Series C funding. Morgan Stanley Expansion Capital led the round with participation from other investors that included New Enterprise Associates, Upfront Ventures and First Round Capital.


NEA to provide $5 mln to Speedinvest’s second fund

New Enterprise Associates is planing on making a $5 million investment in Speedinvest’s newly launched second fund. NEA is anticipating that it will provide $50 million in follow-on funding for Speedinvest’s portfolio companies. Speedinvest’s second fund will focus on backing European startups.


MuleSoft racks up $128 mln

MuleSoft, a platform provider that helps businesses with connectivity, has secured $128 million in funding. Salesforce Ventures led the round with participation from other investors that included ServiceNow, Cisco Investments, Adage Capital Management, Brookside Capital, Sands Capital Ventures, New Enterprise Associates, Lightspeed Venture Partners, Meritech Capital Partners, Bay Partners and Hummer Winblad Venture Partners. Goldman, Sachs & Co was the placement agent for the transaction.


Cortendo to raise about $33.2 mln in a private placement

Cortendo AB has agreed to raise about $33.2 million in a private placement. Investors in this round include Longwood Capital, TVM Capital, Granite Point Capital, RA Capital, New Enterprise Associates, Broadfin Capital and HealthCap. Also, Cortendo has agreed to buy Aspireo Pharmaceuticals’ Somatoprim, which is being studied in the treatment of acromegaly. The value of the acquisition is about $30 million. Headquartered in Göteborg, Sweden and with offices in Radnor, Pennsylvania, Cortendo is a biopharmaceutical firm focused on orphan endocrine disorders.


NEA leads $38.9 mln Series B funding in Intact Vascular

New Enterprise Associates led a $38.9 million Series B funding round in Intact Vascular, Inc., which develops medical devices for minimally invasive vascular procedures. Other participants in the funding included Quaker Partners, H.I.G. BioVentures and other existing investors. NEA Partner Justin Klein joined Intact Vascular’s board. Press Release Intact Vascular, Inc., a developer of medical […]

NEA leads Series D round for Cartiva

Alpharetta, Georgia-based Cartiva Inc, a provider of solutions for patients with osteoarthritis or cartilage damage, has raised $8.5 million in Series D funding. New Enterprise Associates led the round with participation from Windham Ventures Partners.


Robinhood scores $50 mln in NEA-led round

Retail brokerage platform Robinhood has raised $50 million in funding, the company announced in a blog post on its site. New Enterprise Associates led the round with participation from Index Ventures, Ribbit Capital, Social Leverage and Vaizra Investments. In addition to the funding, Kittu Kolluri of NEA has been added to Robinhood’s board of directors.

Moximed picks up about $33 mln

Hayward, California-based Moximed, a maker of solutions for patients with knee osteoarthritis, has secured about $33 million in funding. The investors included Vertex Venture Holdings Ltd, New Enterprise Associates, Gilde Healthcare Partners, Morgenthaler Ventures and GBS Venture Partners. In addition to the funding, Dr. Christopher Shen of Vertex, has been added to Moximed’s board of directors.

NVCA appoints True Ventures’ Callaghan as chairman

The National Venture Capital Association has named Jon Callaghan chairman of its board of directors. A founder and general partner of True Ventures, Callaghan is succeeding Scott Sandell, general partner of New Enterprise Associates. In addition to this appointment, ten new board members were announced at NVCA’s annual meeting held in San Francisco. Among them are Mike Carusi, general partner of Lightstone Ventures; Jeff Clavier, founder and managing director of SoftTech VC; Michael Dixon, a partner at Sequoia Capital; and Mary Meeker, a partner at Kleiner Perkins Caufield & Byers.


CRISPR Therapeutics raises $64 mln

CRISPR Therapeutics said Wednesday it raised $64 million in financing, including $35 million in a Series A and $29 million in a Series B. Strategic investors, SR One and Celgene Corp., led the rounds while new investors New Enterprise Associates and Abingworth, alongside the Company’s founding investor, Versant Ventures, also participated. CRISPR Therapeutics, of Basel, Switzerland, is a biopharmaceutical company.


Xplore closes buy of VC-backed Motion Computing

Xplore Technologies Corp. has completed its previously announced acquisition of substantially all of the assets of Austin, Texas-based Motion Computing Inc, a maker of rugged tablet PCs. The value of the transaction is about $9 million, which includes $7 million in net liabilities. Motion Computing’s backers included New Enterprise Associates, Institutional Venture Partners and G-51 Capital.

PE HUB Community

Join the 12522 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget